Biotech

All Articles

Daiichi pays out Merck $170M to develop lung cancer T-cell engager deal

.Merck &amp Co. has actually rapidly gotten back some of the prices of its own Harpoon Therapies acq...

BioMarin stops preclinical genetics treatment for heart disease

.After BioMarin conducted a spring well-maintained of its own pipe in April, the firm has made a dec...

Eisai plants molecular adhesive SEED with $1.5 B biobucks deal

.Huge Pharmas continue to be caught to the concept of molecular glue degraders. The most recent busi...

Life scientific research credit history agency reveals with $600M

.A brand new worldwide life scientific research credit scores agency, termed Symbiotic Resources, ha...

BMS ditches TIGIT, walking away from $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing one more big wager coming from the Caforio period, ending an...

Nuvation stops wager inhibitor after thinking about phase 1 data

.After checking out at phase 1 information, Nuvation Biography has actually made a decision to halt ...

' Medical intuitiveness' led FDA consultants to back Zevra's uncommon illness med

.Zevra Therapies' uncommon disease drug seems to become on the pathway to approval this autumn after...

Pfizer takes $230M reached after axing stopped working DMD gene treatment

.Pfizer's period 3 Duchenne muscular dystrophy (DMD) genetics treatment breakdown has blown a $230 t...

AC Immune finds 'landmark' potential in Alzheimer's medication data

.After more than twenty years of service neurodegenerative ailments, Swiss biotech hvac Immune syste...

GSK drops ph. 2 HPV vaccination over shortage of best-in-class potential

.GSK has actually ditched a stage 2 human papillomavirus (HPV) injection from its own pipe after cho...